Rush University Cancer Center — Chicago, Illinois

Rush University Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Rush University Cancer Center has participated in 12 clinical trials with 4 currently active.

Therapeutic areas: Solid Tumor, Lymphoma, Prostate Cancer Metastatic Castration-Resistant.

Sponsors: MultiVir, Inc., Northwestern University, CivaTech Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush University Cancer Center?

Rush University Cancer Center has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush University Cancer Center conducted?

Rush University Cancer Center has 12 clinical trials on record, with 4 currently active. Their work covers Solid Tumor, Lymphoma, Prostate Cancer Metastatic Castration-Resistant.

Is Rush University Cancer Center accredited by Crixeo Clinical Trials?

Rush University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.